Novobeing Welcomes Ted Schilowitz as Strategic Investor and Executive Team Member

In Virtual Reality News

December 4, 2024 – Novobeing, a provider of medical virtual reality solutions for enhanced patient care, has this week announced that Ted Schilowitz—founding member of RED Digital Cinema and former Futurist at Paramount Pictures and 20th Century Fox—has become a strategic investor in the company as well as a member of its executive team.

Novobeing focuses on leveraging virtual reality (VR) to provide mental health and well-being support during in-hospital procedures that often leave patients confined for extended periods. The company noted that hospital stays, particularly for cancer treatments or other intensive procedures, are often accompanied by significant distress, including pain, anxiety, and stress. Novobeing’s platform is designed to address these challenges by delivering a range of therapeutic programs tailored to improve mental and emotional resilience.

According to Novobeing, Schilowitz’s journey into healthcare technology stems from a deeply personal experience. After two life-threatening surgeries left him confined to a hospital bed, Schilowitz experienced firsthand the challenges patients face—anxiety, pain and long, emotionally draining days with little to engage the mind or lift the spirit.

From Cognitive Behavioral Therapy (CBT) and Positive Psychology interventions to soothing meditation sessions and immersive VR travel experiences, Novobeing’s platform helps patients to manage their anxiety, reduce their perception of pain, and alleviate the emotional strain that comes with prolonged hospital stays.

“With immersive technology we can turn sterile hospital rooms into places of hope and healing—where patients find relief, comfort, and even joy during their toughest times,” said Schilowitz. “Today’s powerful and accessible hardware allows us to reimagine this technology, moving beyond entertainment to make a profound impact on healing and well-being in healthcare.”

Novobeing stated that as a member of the company’s executive team, Schilowitz will bring his expertise in immersive technologies and his global network to shape Novobeing’s strategic vision, enhance its brand presence, and accelerate the adoption of its medical VR solutions in healthcare systems worldwide. Schilowitz will also help to spearhead product innovation while serving as a global advocate for Novobeing, championing the integration of immersive technology in healthcare at industry events, panel discussions, and engagements with key stakeholders to showcase the company’s solutions.

Novobeing noted that with researchers and developers leveraging VR’s potential for clinical applications, medical VR continues to demonstrate its potential as a tool for delivering mental health treatment. The company also highlighted that regulatory agencies have approved 60+ medical devices that use VR or augmented reality (AR) technology, and that there are currently over 300 published studies that explore VR’s potential for assessing, understanding, and treating various mental health conditions.

Novobeing stated that since its founding, and with the addition of Schilowitz’s strategic investment, the company has to-date secured over USD $1 million in funding to advance its technology, conduct multiple successful clinical trials, and deploy its solutions in hospitals across the United States.

For more information on Novobeing and its virtual reality patient experience platform, please visit the company’s website.

Image credit: Novobeing

About the author

Sam Sprigg

Sam is the Founder and Managing Editor of Auganix. With a background in research and report writing, he has been covering XR industry news for the past seven years.